RNAIMMUNE, INC.
3Patents
3Active
3Granted
56Portfolio score
Filing activity: Feb 8, 2021 → Feb 9, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12029786B2 | Composition and method of mRNA vaccines against novel coronavirus infection | Chemistry; Metallurgy | 1 | Active |
| US12280104B2 | Composition and methods for MRNA vaccines against novel omicron coronavirus infections | Chemistry; Metallurgy | 0 | Active |
| US12280105B2 | Compositions and methods of mRNA vaccines against novel coronavirus infection | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.